Mr. Carchedi is currently President & Chief Executive Officer of Apexian Pharmaceuticals, an early stage oncology discovery and development company focused in novel targets to treat cancer. Having held key positions at several leading multinational pharmaceutical companies, Mr. Carchedi brings more than 30 years of commercial industry experience focused in Oncology, Neurology, Urology, Endocrinology and Cardiology. He has previously served as Chief Executive Officer of Cornerstone Pharmaceuticals, an oncology company focused in cancer metabolism. Mr. Carchedi served as the Senior Vice President and President, Commercial Operations (North America) for Mallinckrodt Pharmaceuticals. In addition to his industry experience, Mr. Carchedi currently serves on the Board of Directors of Sunesis Pharmaceuticals, Bionumerik Pharmaceuticals, and Apexian Pharmaceuticals. Mr. Carchedi also previously served on the Board of Directors for Cornerstone Pharmaceuticals and PCAsso Diagnostics, LLC. He also served as Co-Chair of the BioNJ Personalized Medicine & Diagnostics Committee Council (CMOC), the Ontario Institute of Cancer Research Commercial Committee (OICR) and the Pharmaceutical Industry Board of the American Pediatric Family Foundation. Mr. Carchedi received a B.S. in Marketing from West Chester University and an MBA in Marketing from Drexel University.

 Pharmaceutics